Hematological and biochemical screening of blood donors in the Republic of Bashkortostan
- Authors: Sultanbaev US1, Ayupova RF1, Salikhova AK1, Absalyamova LA1, Khabibullina Y.A1, Zakirova IR2, Talipova RA2, Kuz’min NS2, Vergopulo AA1, Kayumova LI1
-
Affiliations:
- Republican Blood Transfusion Centre, Ufa, Russia
- National Medical and Surgical Centre named after N.I. Pirogov, Moscow, Russia
- Issue: Vol 96, No 3 (2015)
- Pages: 432-437
- Section: Transfusiology of the XXI century: problems, goals, future perspectives
- URL: https://bakhtiniada.ru/kazanmedj/article/view/1680
- DOI: https://doi.org/10.17750/KMJ2015-432
- ID: 1680
Cite item
Full Text
Abstract
Aim. To assess the hematological and biochemical screening effectiveness in blood donors in the Republic of Bashkortostan.
Methods. The results of hematological and biochemical screening in blood donors in the Republic of Bashkortostan in 2008-2013 were studied.
Results. Centralizing and modernizing of blood donors examinations at the Republican Blood Transfusion Centre of the Bashkortostan Republic in 2008-2013 has led to an increase in the number of clinical blood analyses by 53.1%, reaching from 74.1 to 666.9% for some parameters. Studying platelet counts allows to choose platelets donors, whose blood is optimally used for preparing platelet-rich transfusion media. Leukocytosis (5.01%, 1748 of 34 899 subjects), leukopenia (0.1%; 34 of 34 899 subjects) and alterations in erythrocyte sedimentation rate (4.83%, 1574 of 32 581 subjects) may indicate a bacterial infection. In the presence of these signs, it might be appropriate do disallow donating platelets to prevent bacterial contamination of platelet concentrates and complications in the recipient, all the more so as the current mandatory control of blood products sterility is far from being perfect. Deviations in reticulocytes levels during the 6 years of follow up was discovered in 26 (0.05%) of 52 379 donors and in all cases was associated with a low concentration of hemoglobin. Obviously, the screening of this indicator is needless. The substantial part of potential donors infected with hepatitis B virus (80.6%) and C (65.2%) showed no evidence of cytolysis, which once again raises the question of the diagnostic value of alanine aminotransferase level screening in blood donors testing.
Conclusion. The excessiveness for combined screening for hemoglobin and hematocrit levels, reticulocyte concentrations, bilirubin levels was demonstrated. Efforts targeted at the forming of stable population of donors reduced the donation exemptions due to low hemoglobin level and presence of specific markers for viral hepatitis.
About the authors
U S Sultanbaev
Republican Blood Transfusion Centre, Ufa, Russia
Author for correspondence.
Email: ezhiburt@yandex.ru
R F Ayupova
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
A K Salikhova
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
L A Absalyamova
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
Yu A Khabibullina
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
I R Zakirova
National Medical and Surgical Centre named after N.I. Pirogov, Moscow, Russia
Email: ezhiburt@yandex.ru
R A Talipova
National Medical and Surgical Centre named after N.I. Pirogov, Moscow, Russia
Email: ezhiburt@yandex.ru
N S Kuz’min
National Medical and Surgical Centre named after N.I. Pirogov, Moscow, Russia
Email: ezhiburt@yandex.ru
A A Vergopulo
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
L I Kayumova
Republican Blood Transfusion Centre, Ufa, Russia
Email: ezhiburt@yandex.ru
References
- Белякова В.В., Гукасян И.А., Донская О.В. и др. Целесообразность исследования активности аланинаминотрансферазы у доноров крови и её компонентов // Вестн. службы крови России. - 2012. - №4. - С. 12-15.
- Жибурт Е.Б. Трансфузиология: учебник. - СПб: Питер, 2002. - 736 с.
- Жибурт Е.Б. Аланинаминотрансфераза - суррогатный маркёр вирусного гепатита // Вопр. вирусол. - 2005. - Т. 50, №6. - С. 18-19.
- Жибурт Е.Б. Об АЛТ и не только // Трансфузиология. - 2004. - Т. 5, №1. - С. 102-106.
- Жибурт Е.Б., Абжуева О.В., Атакишиев М.М. и др. Значимость активности аланинаминотрансферазы как суррогатного маркёра гемотрансмиссивных инфекций - итоги национального исследования // Вестн. службы крови России. - 2005. - №2. - С. 22-27.
- Жибурт Е.Б., Бельгесов Н.В., Ващенко Т.Н. и др. Аланинаминотрансфераза - суррогатный маркёр вирусного гепатита // Вопр. вирусол. - 1995. - Т. 40, №1. - С. 25-27.
- Жибурт Е.Б., Вергопуло А.А., Максимов В.А., Копченко Т.Г. Эффективность и экономика бактериологического контроля компонентов крови // Эпидемиол. и инфекц. бол. - 2010. - №5. - С. 35-40.
- Жибурт Е.Б., Коденев А.Т. Предварительный скрининг активности аланинаминотрансферазы повышает экономическую эффективность заготовки крови // Клин. лаб. диагностика. - 2009. - №11. - С. 14-16.
- Жибурт Е.Б., Мадзаев С.Р., Магзумова Р.З. Методические вопросы скрининга инфекций у доноров крови // Вестн. службы крови России. - 2013. - №1. - С. 30-32.
- Коденев А.Т., Губанова М.Н., Жибурт Е.Б. Гемоцитологический скрининг доноров крови // Вестн. службы крови России. - 2010. - №1. - С. 19-23.
- Приказ Минздрава РФ от 14.09.2001 №364 «Об утверждении порядка медицинского обследования донора крови и её компонентов».
- Филина Н.Г., Колотвина Т.Б., Титова С.А., Жибурт Е.Б. Диагностическая значимость определения активности аланинаминотрансферазы донорской крови // Трансфузиология. - 2011. - Т. 12, №1. - С. 9-12.
- Филина Н.Г., Колотвина Т.Б., Титова С.А., Жибурт Е.Б. Предварительный скрининг активности аланинаминотрансферазы у доноров утратил экономическую эффективность // Трансфузиология. - 2011. - Т. 12, №3. - С. 61-64.
- Чечёткин А.В., Данильченко В.В., Григорьян М.Ш. и др. Деятельность учреждений службы крови Российской Федерации в 2013 году // Трансфузиология. - 2014. - Т. 14, №3. - С. 4-14.
- Annen K., Delaney M., Leitch D. et al. The health implications of low hemoglobin deferral in infrequent blood donors // Transfusion. - 2015. - Vol. 55, N 1. - P. 86-90. http://dx.doi.org/10.1111/trf.12801
- Engle R.E., Bukh J., Alter H.J. et al. Transfusion-associated hepatitis before the screening of blood for hepatitis risk factors // Transfusion. - 2014. - Vol. 54, N 11. - P. 2833-2841. http://dx.doi.org/10.1111/trf.12682
- Gonçalez T.T., Sabino E.C., Schlumpf K.S. et al. Analysis of donor deferral at three blood centers in Brazil // Transfusion. - 2013. - Vol. 53, N 3. - P. 531-538. http://dx.doi.org/10.1111/j.1537-2995.2012.03820.x
- Madrona D.P., Herrera M.D., Jimenez D.P. et al. Women as whole blood donors: offers, donations and deferrals in the province of Huelva, south-western Spain // Blood Transfusion. - 2014. - Vol. 12, suppl. 1. - P. 11.
- Ngoma A.M., Goto A., Nollet K.E. et al. Blood donor deferral among students in northern Japan: challenges ahead // Transfus. Med. Hemotherapy. - 2014. - Vol. 41, N 4. - P. 251. http://dx.doi.org/10.1159/000365406
- Popovsky M.A. Anemia, iron depletion, and the blood donor: it’s time to work on the donor’s behalf // Transfusion. - 2012. - Vol. 52, N 4. - P. 688-692. http://dx.doi.org/10.1111/j.1537-2995.2012.03562.x
- Smith G.A., Fisher S.A., Doree C. et al. A systematic review of factors associated with the deferral of donors failing to meet low haemoglobin thresholds // Transfusion Med. - 2013. - Vol. 23, N 5. - P. 309-320. http://dx.doi.org/10.1111/tme.12046
- Van Hove L., Schisano T., Brace L. Anemia diagnosis, classification, and monitoring using cell-dyn technology reviewed for the new millennium // Lab. Hematol. - 2000. - Vol. 6. - P. 93-108.
Supplementary files
